Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wistuba

Showing results (241-250 of 671) with videos related to

Pageof 68
Sort By:
Cancer|September 29, 2011
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Molecular Endocrinology (Baltimore, Md.)|June 16, 2012
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancerYangsik Jeong, Yang Xie, Woochang Lee, et al.
Oncotarget|May 7, 2015
Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung CancerRitsuko Komaki, Pamela K Allen, Xiong Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Comparison of features of human breast cancer cell lines and their corresponding tumorsI I Wistuba, C Behrens, S Milchgrub, et al.
Plos One|May 1, 2009
Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinomaDon L Gibbons, Wei Lin, Chad J Creighton, et al.
Nature Reviews. Clinical Oncology|February 13, 2021
PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Clinical Pharmacology and Therapeutics|September 12, 2017
Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1Liren Zhang, Jing Lin, Yuanqing Ye, et al.
Pageof 68

Showing results (241-250 of 671) with videos related to

Sort By:
Pageof 68
Cancer|September 29, 2011
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Molecular Endocrinology (Baltimore, Md.)|June 16, 2012
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancerYangsik Jeong, Yang Xie, Woochang Lee, et al.
Oncotarget|May 7, 2015
Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung CancerRitsuko Komaki, Pamela K Allen, Xiong Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Comparison of features of human breast cancer cell lines and their corresponding tumorsI I Wistuba, C Behrens, S Milchgrub, et al.
Plos One|May 1, 2009
Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinomaDon L Gibbons, Wei Lin, Chad J Creighton, et al.
Nature Reviews. Clinical Oncology|February 13, 2021
PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Clinical Pharmacology and Therapeutics|September 12, 2017
Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1Liren Zhang, Jing Lin, Yuanqing Ye, et al.
Pageof 68